[1] | Baggino L., Drucker D. biology of incretins: GLP-1 and GIP // Gastroenterology.- 2007.-№ 132: 2131-57. |
[2] | Bouloumié A., Curat C.A.., Sengenès C. et al. Role of macrophage tissue infiltration in metabolic diseases.// Curr Opin Clin Nutr Metab Care, 2005, no.l; 8(4), pp.347–354. |
[3] | Bouwman J.J., Visseren F.L., Bouter K.P. et al. Infection-induced inflammatory response of adipocytes in vitro.// Int J Obes (Lond), 2008, no.32(6), pp. 892–901. doi: 10.1038/ijo.2008.36. |
[4] | Calabro P., Yeh E.T. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. //Curr Hypertens Rep., 2008, no. 10(1), pp.32–38. |
[5] | Calabro P., Yeh E.T. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. // Subcell Biochem. 2007, no. 42, pp. 63–91. |
[6] | Chevallier JM. From bariatric to metabolic surgery: 15 years experience in a French university hospital.[Article in French] // Bull Acad Natl Med. 2010 Jan;194(1):25-36; discussion 36-8. |
[7] | Countinbo T., Goel K., Correa de SA D. Combining body mass with measurment of central obesity in the assesment of mortality with coronary disease – role of normal weight central obesity // J Cardiol 2013.-61(3).- 553-560. |
[8] | Dedov I.I., Yashkov Yu.I., Ershova E.V. Incretins and their effect on the course of type 2 diabetes in patients with morbid obesity after bariatric operations // Obesity and Metabolism. 2012.-№2.- P. 3-10. |
[9] | Esser N., Legrand-Poels S., Piette J. et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. //Diabetes Res Clin Pract. 2014, no. 105(2), pp.141–150. doi: 10.1016/j.diabres.2014.04.006. |
[10] | Fernández-Bergés D, Consuegra-Sánchez L, Peñafiel J, Cabrera de León A, Vila J, Félix-Redondo FJ6, Segura-Fragoso A7, Lapetra J8, Guembe MJ9, Vega T10, Fitó M11, Elosua R3, Díaz O12, Marrugat J3.Metabolic and inflammatory profiles of biomarkers in obesity, metabolic syndrome, and diabetes in a Mediterranean population. DARIOS Inflammatory study.// Rev Esp Cardiol (Engl Ed). 2014 Aug;67(8):624-31. doi: 10.1016/j.rec.2013.10.019. Epub 2014 Apr 3. |
[11] | Furuhashi M., Saitoh S., Shimamoto K. et al. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. // Clin Med Insights Cardiol. 2015, no. 2;8 (Suppl 3), pp. 23–33. doi: 10.4137/CMC.S17067. |
[12] | Heilbronn L.K., Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.// Curr Pharm Des., 2008, no. 14(12), pp.1225–1230. |
[13] | Holvoet P.Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.// Verh K Acad Geneeskd Belg. 2008;70(3):193-219. |
[14] | Immonen H, Hannukainen JC, Iozzo P, Soinio M, Salminen P, Saunavaara V, Borra R, Parkkola R, Mari A, Lehtimäki T, Pham T, Laine J, Kärjä V, Pihlajamäki J, Nelimarkka L, Nuutila P. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.// J Hepatol. 2014 Feb;60(2):377-83. doi: 10.1016/j.jhep.2013.09.012. Epub 2013 Sep 20. |
[15] | Jacobs E.J. Newton C.C., Wang Y Waist circumference increasing cause mortality in large US cohort // Arch Internal Med 2010.-17.-123-130. |
[16] | Janket S.J., Ackerson LK What is passing through toll gate 4: Lipids or infection?// Arch Oral Biol. 2015 Jan 20. pii: S0003-9969(15)00018-7. doi:10.1016/j.archoralbio.2015.01.007. |
[17] | Jarvis M.A., Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages.// Curr Opin Microbiol. 2002 Aug;5(4):403-7. |
[18] | Ji YN, An L, Zhan P, Chen XH.Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.// Mol Biol Rep. 2012Jun;39(6):6537-46.doi: 0.1007/s11033-012-1482-6. Epub 2012 Feb 4. |
[19] | Kasalický M. Contemporary overview of the bariatric-metabolic surgery // Rozhl Chir.- 2012 Jan;91(1):5-11. |
[20] | Kelishadi R, Mansourian M, Heidari-Beni M. Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis//Nutrition. 2014 May;30(5):503-10. doi: 10.1016/j.nut.2013.08.014. |
[21] | Khaybullina Z., Zyamutdinova Z., Suleymanova G., Kosnikova I. Biomarkers of the system inflammation and blood lipids spectrum changes at the patients with obesity of various degree // Universum - Medicine et Pharmacology - 2015.-№12(23). |
[22] | Khaybullina Z.R. Inflammation and oxidative stress – critical role for metabolic syndrome// J Vasc Med Surg 2017; 5: 302. doi: 10.4172/2329-6925.1000302/. |
[23] | Kosnikova I.V., Bazhenov L.G., Nizamkhodzhayev Z.M., Ligay R.E. The metabolic effects of surgical treatment of patients with morbid obesity // Bulletin of the Association of Doctors of Uzbekistan, 2012, № 2, p. 84-86. |
[24] | Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B, Dagenais GR, Després JP. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?// Can J Cardiol. 2007 Oct;23 Suppl B:23B-31B. |
[25] | Litvinova L.S., Vasilenko M.A., Zatolokin P.A. et al. Adipocytokine production in patients with morbid obesity with various treatment methods // Diabetes. - 2014. - № 3. - P. 51–59. doi: 10.14341 / DM2014351-59. |
[26] | Lima KV, Costa MJ, Gonçalves Mda C, Sousa BS. Micronutrient deficiencies in the pre-bariatric surgery //Arq Bras Cir Dig. 2013;26 Suppl 1:63-6. |
[27] | Maggard M.A. MD, MSHS; Lisa R. Shugarman, PhD; Marika Suttorp, MS; Margaret Maglione, MPP; Harvey J. Sugerman, MD; Edward H. Livingston, MD; Ninh T. Nguyen, MD; Zhaoping Li, MD, PhD; Walter A. Mojica, MD, MPH; Lara Hilton, BA; Shannon Rhodes, MFA; Sally C. Morton, PhD; and Paul G. Shekelle, MD, PhD.- Meta-Analysis: Surgical Treanment of Obesity (Guidelines) // Ann Int Med.-2003.-V.142.-№ 7.-Р.547-559. |
[28] | Makhmudov U M, Khashimov Sh Kh Khaybullina Z R, Sharapov N U, Sadikov N S, Kabulov T M and Tashkenbaev F R. Effect of intra-gastric balloon installation and laparoscopic sleeve gastrectomy to comorbidity reduction and cardiometabolic disease staging in 6 month after procedure // J Obes Weight Loss Ther 2018, Volume 8.-P.43. DOI: 10.4172/2165-7904-C6-073. |
[29] | Mancini MC. Bariatric surgery - An update for the endocrinologist. // Arq Bras Endocrinol Metabol. 2014 Dec;58(9):875-88. doi: 10.1590/0004-2730000003413. |
[30] | Martínez-Martínez E, Jurado-López R, Cervantes-Escalera P, Cachofeiro V, Miana M. Leptin, a mediator of cardiac damage associated with obesity//Horm Mol Biol Clin Investig. 2014 Apr;18(1):3-14. doi: 10.1515/hmbci-2013-0060. |
[31] | Morre S.A., Stooker W., Lagrand W.K., van den Brule AJC, Niessen HWM. Microorganisms in the aetiology of atherosclerosis // J Clin Pathol.-2000.-53: 647-654. |
[32] | Oliver E., McGillicuddy F., Phillips C. et al. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.// Proc Nutr Soc. 2010, no. 69(2), pp.232–243. doi: 10.1017/S0029665110000042. |
[33] | Risstad H, Søvik TT, Engström M, Aasheim ET, Fagerland MW, Olsén MF, Kristinsson JA, le Roux CW, Bøhmer T, Birkeland KI, Mala T, Olbers T. Five-Year Outcomes After Laparoscopic Gastric Bypass and Laparoscopic Duodenal Switch in Patients With Body Mass Index of 50 to 60: A Randomized Clinical Trial // JAMA Surg. 2015 Feb 4. doi: 10.1001/jamasurg.2014.3579. |
[34] | Ruf W1, Samad FTissue factor pathways linking obesity and inflammation//Hamostaseologie. 2015 Jan 27;35(2). |
[35] | Salazar M.R., Carbajal H.A., Espeche W.G. et al. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio. // Am J Med. 2014, no. 127(2), pp.152–157. doi: 10.1016/j.amjmed.2013.10.012. |
[36] | Samorodskaya I.V., Bolotova E.V., Boytsov S.A. "The obesity paradox" and cardiovascular mortality // Cardiology.-2015.-№55.-P.31-36. |
[37] | Schwarz V.Y. Inflammation of adipose tissue (part 4). Is obesity a new infectious disease? (literature review) // Problems of endocrinology.-2011.-№5.-С.63-71. |
[38] | Spritzer PM1, Lecke SB2, Satler F3, Morsch DMAdipose tissue dysfunction, adipokines and low-grade chronic inflammation in PCOS. // Reproduction. 2015 Jan 27. pii: REP-14-0435. |
[39] | Tsiotra P.C., Boutati E., Dimitriadis G. et al. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. // Biomed Res Int. 2013, no. 20, P. 487081. doi: 10.1155/2013/487081. |
[40] | Vahdat K, Azizi F, Zandi K, Assadi M, Nabipour I. Chronic inflammation is correlated with percentage of body fat independent of the burden of infection.// Inflammation. 2012 Aug;35(4):1322-9. doi: 10.1007/s10753-012-9445-6. |
[41] | Valente DS1, Padoin AV. Post-bariatric surgery body contouring treatment in the public health system: cost study and perception by patients // Plast Reconstr Surg. 2015 Feb 9. |
[42] | Wieser V, Moschen AR, Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. //Arch Immunol Ther Exp (Warsz). 2013 Apr;61(2):119-25. doi: 10.1007/s00005-012-0210-1. Epub 2013 Jan 10. |
[43] | Xiao S, Zhao L. Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation.// FEMS Microbiol Ecol. 2014 Feb;87(2):303-14. doi: 10.1111/1574-6941.12250. Epub 2013 Dec 12. |